- Home
- APLT vs MODV Comparison
APLT vs MODV Comparison
Compare APLT & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MODV
- Stock Information
- Founded
- APLT 2016
- MODV 1996
- Country
- APLT United States
- MODV United States
- Employees
- APLT N/A
- MODV N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- APLT Health Care
- MODV Consumer Discretionary
- Exchange
- APLT Nasdaq
- MODV Nasdaq
- Market Cap
- APLT 44.0M
- MODV 48.9M
- IPO Year
- APLT 2019
- MODV N/A
- Fundamental
- Price
- APLT $0.39
- MODV $4.04
- Analyst Decision
- APLT Buy
- MODV Buy
- Analyst Count
- APLT 7
- MODV 4
- Target Price
- APLT $6.10
- MODV $9.17
- AVG Volume (30 Days)
- APLT 2.5M
- MODV 1.7M
- Earning Date
- APLT 08-06-2025
- MODV 08-06-2025
- Dividend Yield
- APLT N/A
- MODV N/A
- EPS Growth
- APLT N/A
- MODV N/A
- EPS
- APLT N/A
- MODV N/A
- Revenue
- APLT $265,000.00
- MODV $2,753,789,000.00
- Revenue This Year
- APLT $1,768.13
- MODV N/A
- Revenue Next Year
- APLT $292.85
- MODV $4.90
- P/E Ratio
- APLT N/A
- MODV N/A
- Revenue Growth
- APLT N/A
- MODV N/A
- 52 Week Low
- APLT $0.30
- MODV $0.87
- 52 Week High
- APLT $10.62
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- APLT 51.68
- MODV 64.00
- Support Level
- APLT $0.32
- MODV $3.01
- Resistance Level
- APLT $0.36
- MODV $4.06
- Average True Range (ATR)
- APLT 0.03
- MODV 0.42
- MACD
- APLT 0.00
- MODV -0.02
- Stochastic Oscillator
- APLT 73.78
- MODV 79.05
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.